Leukemia Research
Volume 30, Issue 9 , Pages 1077-1078, September 2006

Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies?

University of Arizona Cancer Center, Tucson, AZ, USA

Received 20 March 2006 published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(06)00129-9

doi:10.1016/j.leukres.2006.03.014

Leukemia Research
Volume 30, Issue 9 , Pages 1077-1078, September 2006

Article Tools